New trials a game-changer for latent TB treatment

The results from two clinical trials on the treatment of latent tuberculosis (TB) were recently published in the New England Journal of Medicine. The studies from the Research-Institute of the McGill University Health Centre (RI-MUHC; Montreal, Canada) demonstrated that a shorter treatment was more safe and effective in all age categories.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment